Latest Sabin Vaccine Institute Stories
Research funded by the Dengue Vaccine Initiative (DVI) involving an economic analysis of producing a tetravalent dengue vaccine shows that the cost could be as low as $0.20 per dose with an annual production level of 60 million doses packaged in ten-dose vials.
Researchers at Baylor College of Medicine will receive up to $6.2 million over five years from the National Institute Of Allergy and Infectious Diseases, part of the National Institutes of Health, to develop a vaccine for severe acute respiratory syndrome, commonly called SARS.
The open-access journal PLoS Neglected Tropical Diseases will publish an article emphasizing the rising burden of Neglected Tropical Diseases (NTDs) in Central Asia on Tuesday, Sept. 27th.
WASHINGTON, July 14, 2011 /PRNewswire-USNewswire/ -- The Sabin Vaccine Institute (Sabin) is pleased to announce the election of Baroness Helene Hayman, Gary Rosenthal, Marc Shapiro, and Alisa Swidler to the organization's Board of Trustees.
Despite significant advancements in increasing distribution and development of vaccines against childhood killer diseases â€“ including pneumococcal disease, rotavirus, and Haemophilus influenzae Type B â€“ global efforts to reduce the burden of infection from neglected tropical diseases (NTDs) has greatly lagged.
- A bereavement by loss of parents or children; the state of being orbate; orbation.